City Of Philadelphia Trustee Under The Will Of James Wills
Philadelphia, PA Doing business as The Wills Eye Health System
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 840 Walnut St #1530, Philadelphia, PA 19107, USA
- Website
- willseye.org
- Founded
- 1832
- Employees
- 251-1K
- Estimated annual revenue
- $50M-$100M
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- Health Care Services
- SIC code
- 80 Health Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Grant awards
Latest 5 listed here. See the rest on GovTribe.
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| The Leland Stanford Junior University | UG1EY030417 | $5,670 | |
| University Of Pittsburgh - Of The Commonwealth System Of Higher Education | UG1EY031651 | $14,000 | |
| Northwestern University | U01EY033001 | $309,000 | |
| The Leland Stanford Junior University | UG1EY030417 | $20,935 | |
| Northwestern University | U01EY033001 | $309,000 |
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
About the company
The Wills Eye Health System, the tax-exempt hospital entity of City Of Philadelphia Trustee Under The Will Of James Wills, is a federal grant recipient performing ophthalmology research and clinical trial support for the National Eye Institute (NEI) and other health agencies. The organization operates as a prime recipient on federal grants (80% of recent awards) and as a sub-recipient on university-led research grants (20%), with no federal contract vehicle participation.
The Wills Eye Health System's federal footprint centers on glaucoma research and real-world clinical data analysis. As a prime recipient, the organization holds three active NEI project grants: a five-year award beginning September 2026 on in vivo structural modeling of aqueous outflow dynamics in glaucomatous eyes; a three-year award beginning September 2024 on novel subsampling and analysis methods for big EMR data using the IRIS (Intelligent Research in Sight) registry; and a four-year award beginning August 2023 on longitudinal ocular changes in naturally occurring glaucoma animal models using rhesus macaques. As a sub-recipient, the organization performs clinical trial site operations and patient enrollment for multiple university prime grantees, including management of the DETECT1 and DETECT2 studies (sub-awards from Stanford University awarded July 2025 and July 2026), the COAST (Clarifying the Optimal Application of SLT Therapy) trial (University of Pittsburgh sub-awards May 2023 and May 2026), and clinical glaucoma management enabled by visible-light OCT (Northwestern University sub-awards October 2024 and February 2026).
Customer concentration is heavily weighted toward the National Eye Institute, which accounts for 12 awards across the recent activity set. The Department of Health and Human Services sub-agencies (NEI, Centers for Disease Control and Prevention, and Health Resources and Services Administration) collectively dominate the award count, covering 71% of recent awards. The Department of Justice Bureau of Prisons Federal Correctional Institution Fort Dix and the Department of Defense round out the customer base with smaller award counts. The combined potential value across all recent awards is approximately $106 thousand, though the organization has obligated $50.2 million across these awards — indicating substantial actual federal investment relative to stated potential values on individual awards. Two awards reach ultimate completion within the next twenty-four months, posing modest recompete exposure. The organization's clinical and research capability profile is dominated by NAICS codes in offices of physicians and hospital settings, with PSC coding emphasizing medical R&D and clinical consultation services.
Quick answers
Is City Of Philadelphia Trustee Under The Will Of James Wills registered in SAM.gov?
Yes. City Of Philadelphia Trustee Under The Will Of James Wills's SAM.gov registration is active through August 18, 2027.
What is City Of Philadelphia Trustee Under The Will Of James Wills's CAGE code?
City Of Philadelphia Trustee Under The Will Of James Wills's CAGE code is 41RY9, and its Unique Entity ID (UEI) is Y8LFC4TU2EN8.
What is City Of Philadelphia Trustee Under The Will Of James Wills's most recent federal award?
City Of Philadelphia Trustee Under The Will Of James Wills's most recent federal grant award is In vivo structural-based quantitative modeling of aqueous outflow dynamics in glaucomatous eyes (F31EY039690), from National Eye Institute (NIH), on September 21, 2026.
On GovTribe
See City Of Philadelphia Trustee Under The Will Of James Wills's full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors